Free Trial

The Pennant Group (PNTG) Competitors

The Pennant Group logo
$26.68 -0.61 (-2.24%)
Closing price 04:00 PM Eastern
Extended Trading
$26.70 +0.02 (+0.06%)
As of 05:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PNTG vs. SHC, BTSG, VCYT, LFST, CON, PRVA, SGRY, ADUS, PACS, and ARDT

Should you be buying The Pennant Group stock or one of its competitors? The main competitors of The Pennant Group include Sotera Health (SHC), BrightSpring Health Services (BTSG), Veracyte (VCYT), LifeStance Health Group (LFST), Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), Surgery Partners (SGRY), Addus HomeCare (ADUS), PACS Group (PACS), and Ardent Health Partners (ARDT). These companies are all part of the "healthcare" industry.

The Pennant Group vs.

Sotera Health (NASDAQ:SHC) and The Pennant Group (NASDAQ:PNTG) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, community ranking, risk, valuation, analyst recommendations, media sentiment and institutional ownership.

Sotera Health received 9 more outperform votes than The Pennant Group when rated by MarketBeat users. Likewise, 57.65% of users gave Sotera Health an outperform vote while only 45.98% of users gave The Pennant Group an outperform vote.

CompanyUnderperformOutperform
Sotera HealthOutperform Votes
49
57.65%
Underperform Votes
36
42.35%
The Pennant GroupOutperform Votes
40
45.98%
Underperform Votes
47
54.02%

Sotera Health has higher revenue and earnings than The Pennant Group. The Pennant Group is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sotera Health$1.05B3.74$51.38M$0.2555.39
The Pennant Group$544.89M1.70$13.38M$0.6839.63

Sotera Health presently has a consensus price target of $16.08, indicating a potential upside of 16.15%. The Pennant Group has a consensus price target of $36.00, indicating a potential upside of 33.58%. Given The Pennant Group's stronger consensus rating and higher possible upside, analysts clearly believe The Pennant Group is more favorable than Sotera Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sotera Health
0 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.57
The Pennant Group
0 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.60

In the previous week, Sotera Health and Sotera Health both had 2 articles in the media. Sotera Health's average media sentiment score of 1.89 beat The Pennant Group's score of 1.78 indicating that Sotera Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sotera Health
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
The Pennant Group
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Sotera Health has a beta of 1.92, meaning that its share price is 92% more volatile than the S&P 500. Comparatively, The Pennant Group has a beta of 1.93, meaning that its share price is 93% more volatile than the S&P 500.

Sotera Health has a net margin of 6.31% compared to The Pennant Group's net margin of 3.24%. Sotera Health's return on equity of 42.27% beat The Pennant Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Sotera Health6.31% 42.27% 6.02%
The Pennant Group 3.24%13.47%3.81%

91.0% of Sotera Health shares are held by institutional investors. Comparatively, 85.9% of The Pennant Group shares are held by institutional investors. 55.1% of Sotera Health shares are held by insiders. Comparatively, 5.8% of The Pennant Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Sotera Health beats The Pennant Group on 13 of the 17 factors compared between the two stocks.

Get The Pennant Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for PNTG and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PNTG vs. The Competition

MetricThe Pennant GroupHealth services IndustryMedical SectorNASDAQ Exchange
Market Cap$925.77M$1.01B$5.58B$9.03B
Dividend YieldN/A1.95%5.28%3.98%
P/E Ratio39.6334.7686.9017.42
Price / Sales1.704.261,359.1878.32
Price / Cash35.1125.2044.3037.67
Price / Book5.553.135.104.68
Net Income$13.38M-$177,500.00$117.78M$224.51M
7 Day Performance-3.44%-1.04%1.50%-0.01%
1 Month Performance1.21%3.36%2.80%0.89%
1 Year Performance75.46%190.37%29.47%18.92%

The Pennant Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PNTG
The Pennant Group
4.102 of 5 stars
$26.68
-2.2%
$36.00
+34.9%
+77.7%$916.46M$544.89M39.245,791Positive News
SHC
Sotera Health
3.3941 of 5 stars
$12.98
+2.3%
$16.08
+23.9%
-6.9%$3.68B$1.05B51.923,000
BTSG
BrightSpring Health Services
2.1805 of 5 stars
$18.55
+0.4%
$18.65
+0.6%
+115.6%$3.23B$8.83B-71.3535,000Short Interest ↑
VCYT
Veracyte
3.9804 of 5 stars
$40.58
-1.3%
$41.13
+1.3%
+63.4%$3.14B$361.05M-270.53790Positive News
High Trading Volume
LFST
LifeStance Health Group
1.2797 of 5 stars
$7.99
+0.1%
$8.70
+8.9%
+24.4%$3.06B$1.06B-30.739,325
CON
Concentra Group Holdings Parent
N/A$21.17
+0.7%
$28.50
+34.6%
N/A$2.70B$1.88B0.0011,000Positive News
PRVA
Privia Health Group
2.6747 of 5 stars
$22.24
+1.8%
$24.88
+11.9%
+0.1%$2.67B$1.66B222.421,102
SGRY
Surgery Partners
2.3154 of 5 stars
$20.19
+1.0%
$36.56
+81.1%
-32.9%$2.57B$2.99B-42.0613,500News Coverage
Positive News
Gap Up
ADUS
Addus HomeCare
4.7766 of 5 stars
$133.87
+0.4%
$133.67
-0.2%
+48.4%$2.43B$1.06B30.6334,846Short Interest ↑
News Coverage
PACS
PACS Group
3.7069 of 5 stars
$13.83
0.0%
$34.00
+145.9%
N/A$2.11B$3.11B0.0032,433
ARDT
Ardent Health Partners
N/A$14.10
+2.1%
$22.00
+56.1%
N/A$2.01B$5.71B0.0024,200

Related Companies and Tools


This page (NASDAQ:PNTG) was last updated on 1/28/2025 by MarketBeat.com Staff
From Our Partners